Detailed description page of B3Pdb
This page provides detail information of Selected ID b3pdb_0744 |
| Primary information | |
|---|---|
| B3PDB ID | b3pdb_0744 |
| Peptide Name | Dalargin |
| PEPTIDE SEQUENCE (1-letter) | YaGFLR |
| PEPTIDE SEQUENCE (3-letter) | Tyr-(D)Ala-Gly-Phe-Leu-Arg |
| N-terminal modification | NA |
| C-terminal modification | NA |
| Chemical modification | NA |
| Peptide Length | 6 |
| Conformation | Linear |
| Peptide Nature | NA |
| Source/Origin of peptide | Chemically synthesized |
| SMILES | O=C(O)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C)Cc2ccccc2)CC(C)C)CCCNC(=[N@H])N |
| Cell Line | NA |
| In vitro CONCENTRATION | NA |
| In vitro METHOD | NA |
| In vitro RESULT | NA |
| ANIMAL MODEL | NA |
| In vivo CONCENTRATION | NA |
| In vivo MODE OF DELIVERY | in situ brain perfusion |
| In vivo METHOD | NA |
| In vivo RESULT | NA |
| ACTION | NA |
| TRANSPORT TYPE | Permeability |
| SUBCELLULAR LOCALISATION | NA |
| COMBINATION | NA |
| PHYSICAL CONDITION | NA |
| RESPONSE | Volume of donor compartment |
| RESULT | 0.0167 ml/g |
| LABEL | H3/C14 |
| PMID | 12682214 |